LIFE
Evolve Global Healthcare Enhanced Yield ETF

Full LIFE fund page
VS

Suggested funds:

Select a second ETF to benchmark against Evolve Global Healthcare Enhanced Yield ETF (LIFE). Compare key metrics including year-to-date performance, management fees, sector exposures and underlying assets to ensure you are selecting the best fund for your investment objectives.

NAV Performance and Flows

-6.0-5.0-4.0-3.0-2.0-1.00.0%Apr 20Apr 27May 4May 12May 20

Key Data

Historical performance and flows

As of May 20, 2026
1M3MYTD1Y3Y
Perf.
LIFE
-2.64%-9.03%-7.72%+1.77%-5.03%
Flows
LIFE
-$12 M+$9 M+$21 M+$67 M+$100 M

Exposure

Countries

LIFE
USA
72.00%
Other
23.09%

Sectors

LIFE
Health Care
71.49%
Other
28.51%
As of May 20, 2026

Top 10 Holdings

LIFE
JOHNSON&JOHNSON
6.54%
GILEAD SCIENCES
6.11%
PFIZER
6.06%
MERCK & CO INC
6.00%
AMGEN-T
5.84%
ABBVIE
5.42%
US80105N1054
5.42%
MEDTRONIC PLC
4.91%
STRYKER
4.85%
LILLY
4.64%

Diversification

LIFE
Total weight of top 10 holdings out of 15 total
55.78%

Characteristics

Compare
LIFE
ProviderEvolve ETFs
ManagementActively managed
Benchmark-
Replication Method
Asset ClassEquity
Dividend PolicyDistributing
Trailing 12m distribution yield12.24%
Meets ESG criteriaNo
Inception DateOctober 25, 2017

Recent articles about LIFE

CboeTrackinsight
The ETF Market Canada is brought to you by Cboe in partnership with Trackinsight SA who is providing all the data, analysis and editorial content on this site. Unless explicitly stated as such, any information that you receive is not real-time.

All content on the ETF Market Canada is for your general information use only, Cboe is not responsible for any use of content by you outside this scope. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by Cboe and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
diamonds